Lepu Scientech Medical Technology (Shanghai) Co (HKSE:02291) Piotroski F-Score: 6 (As of Aug. 20, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02291 Lepu Scientech Medical Technology (Shanghai) Co Ltd HKSE:02291
76 GF Score
Price HK$12.18
GF Value HK$44.29
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Lepu Scientech Medical Technology (Shanghai) Co Piotroski F-Score?

Lepu Scientech Medical Technology (Shanghai) Co HKSE:02291 +6.75% 76 Piotroski F-Score is 6 as of Aug. 20, 2026, which is at its 10-year median of 6.00. GuruFocus rates HKSE:02291 with a GF Score™ of 76/100 and a GF Value™ of HK$44.29 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 804 Medical Devices & Instruments companies, Lepu Scientech Medical Technology (Shanghai) Co ranks better than 81.22% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Lepu Scientech Medical Technology (Shanghai) Co has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Lepu Scientech Medical Technology (Shanghai) Co's Piotroski F-Score or its related term are showing as below:

HKSE:02291' s Piotroski F-Score Range Over the Past 10 Years
Min: 5   Med: 6   Max: 6
Current: 6

During the past 7 years, the highest Piotroski F-Score of Lepu Scientech Medical Technology (Shanghai) Co was 6. The lowest was 5. And the median was 6.

Lepu Scientech Medical Technology (Shanghai) Co  (HKSE:02291) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Lepu Scientech Medical Technology (Shanghai) Co Piotroski F-Score Related Terms


Lepu Scientech Medical Technology (Shanghai) Co Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Lepu Scientech Medical Technology (Shanghai) Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lepu Scientech Medical Technology (Shanghai) Co Piotroski F-Score Chart

Lepu Scientech Medical Technology (Shanghai) Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial 5.00 5.00 6.00 6.00 6.00

Lepu Scientech Medical Technology (Shanghai) Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.00 0.00 6.00 0.00 6.00

HKSE:02291 vs ABT, SYK, MDT: Piotroski F-Score Comparison

For the Medical Devices subindustry, Lepu Scientech Medical Technology (Shanghai) Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lepu Scientech Medical Technology (Shanghai) Co Piotroski F-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lepu Scientech Medical Technology (Shanghai) Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Lepu Scientech Medical Technology (Shanghai) Co's Piotroski F-Score falls into.


HKSE:02291
76GF Score
Lepu Scientech Medical Technology (Shanghai) Co Ltd HKSE:02291
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Net Income was HK$264.8 Mil.
Cash Flow from Operations was HK$244.2 Mil.
Revenue was HK$583.2 Mil.
Gross Profit was HK$493.8 Mil.
Average Total Assets from the begining of this year (Dec24)
to the end of this year (Dec25) was (2223.994 + 2318.736) / 2 = HK$2271.365 Mil.
Total Assets at the begining of this year (Dec24) was HK$2,224.0 Mil.
Long-Term Debt & Capital Lease Obligation was HK$0.9 Mil.
Total Current Assets was HK$1,577.9 Mil.
Total Current Liabilities was HK$67.0 Mil.
Net Income was HK$262.2 Mil.

Revenue was HK$503.6 Mil.
Gross Profit was HK$452.7 Mil.
Average Total Assets from the begining of last year (Dec23)
to the end of last year (Dec24) was (2173.271 + 2223.994) / 2 = HK$2198.6325 Mil.
Total Assets at the begining of last year (Dec23) was HK$2,173.3 Mil.
Long-Term Debt & Capital Lease Obligation was HK$1.6 Mil.
Total Current Assets was HK$1,513.3 Mil.
Total Current Liabilities was HK$90.1 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Lepu Scientech Medical Technology (Shanghai) Co's current Net Income (TTM) was 264.8. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Lepu Scientech Medical Technology (Shanghai) Co's current Cash Flow from Operations (TTM) was 244.2. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec24)
=264.834/2223.994
=0.11908036

ROA (Last Year)=Net Income/Total Assets (Dec23)
=262.178/2173.271
=0.12063751

Lepu Scientech Medical Technology (Shanghai) Co's return on assets of this year was 0.11908036. Lepu Scientech Medical Technology (Shanghai) Co's return on assets of last year was 0.12063751. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Lepu Scientech Medical Technology (Shanghai) Co's current Net Income (TTM) was 264.8. Lepu Scientech Medical Technology (Shanghai) Co's current Cash Flow from Operations (TTM) was 244.2. ==> 244.2 <= 264.8 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec24 to Dec25
=0.854/2271.365
=0.00037599

Gearing (Last Year: Dec24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec23 to Dec24
=1.616/2198.6325
=0.000735

Lepu Scientech Medical Technology (Shanghai) Co's gearing of this year was 0.00037599. Lepu Scientech Medical Technology (Shanghai) Co's gearing of last year was 0.000735. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec25)=Total Current Assets/Total Current Liabilities
=1577.891/67.029
=23.5404228

Current Ratio (Last Year: Dec24)=Total Current Assets/Total Current Liabilities
=1513.343/90.135
=16.78973762

Lepu Scientech Medical Technology (Shanghai) Co's current ratio of this year was 23.5404228. Lepu Scientech Medical Technology (Shanghai) Co's current ratio of last year was 16.78973762. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Lepu Scientech Medical Technology (Shanghai) Co's number of shares in issue this year was 346.75. Lepu Scientech Medical Technology (Shanghai) Co's number of shares in issue last year was 346.75. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=493.761/583.233
=0.84659304

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=452.725/503.561
=0.89904699

Lepu Scientech Medical Technology (Shanghai) Co's gross margin of this year was 0.84659304. Lepu Scientech Medical Technology (Shanghai) Co's gross margin of last year was 0.89904699. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec24)
=583.233/2223.994
=0.26224576

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec23)
=503.561/2173.271
=0.23170649

Lepu Scientech Medical Technology (Shanghai) Co's asset turnover of this year was 0.26224576. Lepu Scientech Medical Technology (Shanghai) Co's asset turnover of last year was 0.23170649. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+0+1+1+1+0+1
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Lepu Scientech Medical Technology (Shanghai) Co has an F-score of 6 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 6 mean?
Lepu Scientech Medical Technology (Shanghai) Co (HKSE:02291) has a Piotroski F-Score of 6 as of Aug. 20, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Lepu Scientech Medical Technology (Shanghai) Co and its competitors. This is near median its historical median of 6.00. Over the past decade, Lepu Scientech Medical Technology (Shanghai) Co's Piotroski F-Score has ranged from 5.00 to 6.00. According to the industry distribution chart, Lepu Scientech Medical Technology (Shanghai) Co ranks #151 out of 804 companies in the Medical Devices & Instruments industry, placing it in the top 18.8%.
Is Lepu Scientech Medical Technology (Shanghai) Co's Piotroski F-Score too high?
Lepu Scientech Medical Technology (Shanghai) Co's current Piotroski F-Score of 6 is near median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 5.00 to a high of 6.00. The Medical Devices & Instruments industry median Piotroski F-Score is 5.00. Lepu Scientech Medical Technology (Shanghai) Co's value of 6 is 20% above this industry median. Based on the distribution chart, Lepu Scientech Medical Technology (Shanghai) Co ranks #151 out of 804 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Lepu Scientech Medical Technology (Shanghai) Co has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Lepu Scientech Medical Technology (Shanghai) Co's Piotroski F-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Lepu Scientech Medical Technology (Shanghai) Co ranks #151 out of 804 companies for Piotroski F-Score. This places Lepu Scientech Medical Technology (Shanghai) Co in the top 19% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Lepu Scientech Medical Technology (Shanghai) Co's value of 6 is 20% above this benchmark. Historically, Lepu Scientech Medical Technology (Shanghai) Co's own Piotroski F-Score has ranged from 5.00 to 6.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, Lepu Scientech Medical Technology (Shanghai) Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Devices & Instruments company?
The median Piotroski F-Score among Medical Devices & Instruments companies is 5.00, based on 804 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lepu Scientech Medical Technology (Shanghai) Co's current Piotroski F-Score of 6 is 20% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Lepu Scientech Medical Technology (Shanghai) Co and its competitors. For the Medical Devices & Instruments industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lepu Scientech Medical Technology (Shanghai) Co's current Piotroski F-Score is 6, which is near median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lepu Scientech Medical Technology (Shanghai) Co stock overvalued right now?
Based on GuruFocus' analysis, Lepu Scientech Medical Technology (Shanghai) Co (HKSE:02291) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$44.29, compared to a current price of HK$12.18 — trading 72.5% below its estimated fair value. The current Piotroski F-Score is 6, which is near median its 10-year median of 6.00 and 20% above the Medical Devices & Instruments industry median of 5.00. Lepu Scientech Medical Technology (Shanghai) Co's overall GF Score™ is 76/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Lepu Scientech Medical Technology (Shanghai) Co (HKSE:02291), the current Piotroski F-Score is 6 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lepu Scientech Medical Technology (Shanghai) Co (HKSE:02291) Overvalued in 2026?

Based on GuruFocus' analysis, Lepu Scientech Medical Technology (Shanghai) Co stock appears to be undervalued. The current stock price of HK$12.18 is trading 72.5% below its estimated GF Value™ of HK$44.29. GuruFocus considers Lepu Scientech Medical Technology (Shanghai) Co to be Significantly Undervalued.

Key valuation signals for HKSE:02291:

  • Piotroski F-Score: 6 (near median its 10-year median of 6.00)
  • GF Value™: HK$44.29 vs. price of HK$12.18 (72.5% below fair value)
  • GF Score™: 76/100 with 1 warning sign
  • Industry Position: 20% above the Medical Devices & Instruments median (#151 of 804)

No single metric tells the full story. See the HKSE:02291 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Lepu Scientech Medical Technology (Shanghai) Co Business Description

Address No. 258, Xinzhuan Road, 1st Floor, 5th Floor Building 41, Songjiang District, Shanghai, CHN, 201612
Lepu Scientech Medical Technology (Shanghai) Co Ltd is focused on the research and development, manufacture, and commercialization of heart disease interventional medical devices. The reporting segments of the Group are as follows: The Occluder business segment and The heart valve business segment. The company generates majority of its revenue from the Occluder segment which is engaged in the research and development, manufacturing and sales of interventional treatment series occluders for the defective congenital heart disease.
76GF Score

Get the complete analysis for HKSE:02291

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$12.18
Price
HK$44.29
GF Value